DK174968B1 - Fremgangsmåde til ultraoprensning af faktor VIII:C - Google Patents
Fremgangsmåde til ultraoprensning af faktor VIII:C Download PDFInfo
- Publication number
- DK174968B1 DK174968B1 DK198801840A DK184088A DK174968B1 DK 174968 B1 DK174968 B1 DK 174968B1 DK 198801840 A DK198801840 A DK 198801840A DK 184088 A DK184088 A DK 184088A DK 174968 B1 DK174968 B1 DK 174968B1
- Authority
- DK
- Denmark
- Prior art keywords
- factor
- matrix
- mixture
- solution
- ion exchange
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3280087A | 1987-03-31 | 1987-03-31 | |
US3280087 | 1987-03-31 | ||
US16790288A | 1988-03-28 | 1988-03-28 | |
US16790288 | 1988-03-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
DK184088D0 DK184088D0 (da) | 1988-04-05 |
DK184088A DK184088A (da) | 1988-10-01 |
DK174968B1 true DK174968B1 (da) | 2004-04-05 |
Family
ID=26708905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK198801840A DK174968B1 (da) | 1987-03-31 | 1988-04-05 | Fremgangsmåde til ultraoprensning af faktor VIII:C |
Country Status (7)
Country | Link |
---|---|
US (1) | US5470954C1 (es) |
EP (1) | EP0286323B1 (es) |
JP (1) | JP2686766B2 (es) |
CA (1) | CA1339946C (es) |
DE (1) | DE3886249T2 (es) |
DK (1) | DK174968B1 (es) |
ES (1) | ES2061642T3 (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639624A (en) * | 1989-03-14 | 1997-06-17 | Board Of Regents Of The University Of Nebraska | Monoclonal antibodies specific for metallic cations and method therefor |
WO1990010709A2 (en) * | 1989-03-14 | 1990-09-20 | Board Of Regents Of The University Of Nebraska | Monoclonal antibodies for metallic cations on small molecules |
JPH0327109A (ja) * | 1989-06-24 | 1991-02-05 | Hagiwara Kogyo Kk | 生物分解性フラットヤーンの製造方法 |
US5254532A (en) * | 1989-06-26 | 1993-10-19 | Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte | Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
AT402153B (de) * | 1989-06-26 | 1997-02-25 | Immuno Ag | Protein-s-hältige pharmazeutische präparation |
JPH0427865A (ja) * | 1989-12-21 | 1992-01-30 | Kurita Water Ind Ltd | 血液凝固因子用分離剤およびその製造方法 |
FR2662166A1 (fr) * | 1990-05-18 | 1991-11-22 | Fondation Nale Transfusion San | Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption. |
JPH08506181A (ja) | 1993-01-29 | 1996-07-02 | ダールベック,ビョルン | 新規抗凝固性補助因子活性 |
DE4337573C1 (de) * | 1993-11-04 | 1995-05-18 | Octapharma Ag | Verfahren zur Herstellung einer virusinaktivierten Faktor VIII enthaltenden Fraktion mittels chromatographischer Methoden |
US5589571A (en) * | 1994-10-28 | 1996-12-31 | Cor Therapeutics, Inc. | Process for production of inhibited forms of activated blood factors |
SE503424C2 (sv) * | 1994-11-14 | 1996-06-10 | Pharmacia Ab | Process för rening av rekombinant koagulationsfaktor VIII |
US6111079A (en) * | 1995-06-05 | 2000-08-29 | Bionebraska, Inc. | Lead binding polypeptides and nucleotides coding therefore |
US5659017A (en) * | 1995-11-07 | 1997-08-19 | Alpha Therapeutic Corporation | Anion exchange process for the purification of Factor VIII |
US6379975B1 (en) | 1996-11-27 | 2002-04-30 | T.A.C. Thrombosis And Coagulation Aktiebolag | Methods and reagents for determining protein S |
PT998486E (pt) | 1997-06-13 | 2007-08-21 | Genentech Inc | ''recuperação de proteínas por cromatografia seguida de filtração numa camada carregada'' |
WO1999046299A1 (en) * | 1998-03-12 | 1999-09-16 | Genetics Institute, Inc. | Improved methods for producing factor viii proteins |
US7820796B2 (en) * | 1998-03-12 | 2010-10-26 | Genetics Institute, Llc. | Methods for producing Factor VIII proteins |
PT1308455E (pt) * | 1998-05-06 | 2006-08-31 | Genentech Inc | Composicao compreendendo anticorpos anti-her2 |
US6855509B2 (en) | 2000-12-19 | 2005-02-15 | Instrumentation Laboratory Company | Protein S functional assay and kit therefor |
EP1835938B1 (en) | 2004-12-27 | 2013-08-07 | Baxter International Inc. | Polymer-von willebrand factor-conjugates |
CN1302009C (zh) * | 2005-09-05 | 2007-02-28 | 武汉海特生物制药股份有限公司 | 用有机溶剂病毒灭活法制备鼠神经生长因子的工艺 |
KR20080108147A (ko) * | 2006-03-31 | 2008-12-11 | 백스터 인터내셔널 인코포레이티드 | 페질화된 인자 viii |
US7645860B2 (en) | 2006-03-31 | 2010-01-12 | Baxter Healthcare S.A. | Factor VIII polymer conjugates |
KR100791502B1 (ko) | 2006-09-29 | 2008-01-03 | 한스바이오메드 주식회사 | 바이러스 불활화된 무세포 인체 이식재 생산방법 |
NZ600053A (en) * | 2007-12-28 | 2013-06-28 | Baxter Int | Counter-Pressure Filtration of Proteins |
TWI472339B (zh) | 2008-01-30 | 2015-02-11 | Genentech Inc | 包含結合至her2結構域ii之抗體及其酸性變異體的組合物 |
US8945895B2 (en) | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
TW201213342A (en) * | 2010-09-17 | 2012-04-01 | Baxter Int | Stabilization of immunoglobulins and other proteins through aqueous formulation with sodium chloride at weak acidic to neutral pH |
EP2652491B1 (en) | 2010-12-15 | 2017-11-29 | Baxalta GmbH | Eluate collection using conductivity gradient |
AU2012324020A1 (en) * | 2011-12-30 | 2013-07-18 | Grifols, S.A. | Method for purifying Factor VIII |
US9700486B2 (en) | 2013-04-24 | 2017-07-11 | Corning Incorporated | Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients |
EP3008085A4 (en) * | 2013-06-13 | 2017-05-10 | Biogen MA Inc. | Anti-factor viii antibodies or uses thereof |
CA3047349C (en) | 2017-01-17 | 2020-09-22 | Genentech, Inc. | Subcutaneous her2 antibody formulations |
RS65204B1 (sr) | 2017-03-02 | 2024-03-29 | Genentech Inc | Adjuvansni tretman her2-pozitivnog raka dojke |
US20220380439A1 (en) | 2020-11-09 | 2022-12-01 | Takeda Pharmaceutical Company Limited | Purification of fviii from plasma using silicon oxide adsorption |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3962421A (en) * | 1973-06-18 | 1976-06-08 | American Home Products Corporation | Method for the disruption of lipid-containing viruses |
US4086218A (en) * | 1975-04-11 | 1978-04-25 | Edward Shanbrom, Inc. | Method of preserving blood plasma II |
US4188318A (en) * | 1975-06-16 | 1980-02-12 | Edward Shanbrom | Simplified method for preparation of high yield, high purity Factor VIII concentrate |
DE2550011C2 (de) * | 1975-11-07 | 1982-11-25 | Behringwerke Ag, 3550 Marburg | Verfahren zur Herstellung eines antihämophilen Mittels |
US4314997A (en) * | 1980-10-06 | 1982-02-09 | Edward Shanbrom | Purification of plasma protein products |
US4315919A (en) * | 1980-10-06 | 1982-02-16 | Edward Shanbrom | Depyrogenation process |
US4412985A (en) * | 1980-10-06 | 1983-11-01 | Edward Shanbrom | Depyrogenation process |
US4490290A (en) * | 1981-02-26 | 1984-12-25 | Internationale Octrooi Maatschappij "Octropa" B.V. | Process for the recovery of immunoglobulins |
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
USRE32011E (en) * | 1981-12-14 | 1985-10-22 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
US4591505A (en) * | 1982-04-14 | 1986-05-27 | New York Blood Center, Inc. | Process for inactivating hepatitis B virus |
US4481189A (en) * | 1982-04-14 | 1984-11-06 | New York Blood Center Inc. | Process for preparing sterilized plasma and plasma derivatives |
US4581231A (en) * | 1982-06-10 | 1986-04-08 | The United States Of America As Represented By The Secretary Of Health And Human Services | Inactivation of viruses containing essential lipids |
US4511556A (en) * | 1982-06-10 | 1985-04-16 | The United States Of America As Represented By The Department Of Health And Human Services | Inactivation of a lipid virus |
US4485017A (en) * | 1982-12-22 | 1984-11-27 | Cetus Corporation | Isolation of human interferon by immunosorbent and high performance liquid chromatography |
US4558006A (en) * | 1983-02-04 | 1985-12-10 | Kirin-Amgen, Inc. | A.T.C.C. HB8209 and its monoclonal antibody to erythropoietin |
JPH0686480B2 (ja) * | 1983-02-21 | 1994-11-02 | 雪印乳業株式会社 | エリスロポエチン製造用モノクローナル抗体 |
ZA842418B (en) * | 1983-03-31 | 1984-11-28 | Scripps Clinic Res | Factor viii coagulant polypeptides and monoclonal antibodies to them |
US4657894A (en) * | 1983-03-31 | 1987-04-14 | Scripps Clinic & Research Foundation | New factor VIII coagulant polypeptides |
US5214033A (en) * | 1983-03-31 | 1993-05-25 | Scripps Clinic & Research Foundation | Factor VIII coagulant polypeptides |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
ATE111490T1 (de) * | 1983-10-28 | 1994-09-15 | New England Medical Center Inc | Verfahren zur isolierung eines proteins aus einer dieses protein enthaltenden mischung unter verwendung eines konformationsspezifischen antikörpers. |
DE10399011I1 (de) * | 1984-01-12 | 2003-10-23 | Chiron Corp | F}r Fakton-VIIIc kodierende DNA-Sequenzen und ver wandte DNA-Konstruktionen |
US4578335A (en) * | 1984-05-21 | 1986-03-25 | Immunex Corporation | Interleukin 2 receptor |
WO1986000910A1 (en) * | 1984-07-30 | 1986-02-13 | Celltech Limited | Immunopurification process |
JPS6151000A (ja) * | 1984-08-17 | 1986-03-13 | Toray Ind Inc | ヒト・インタ−フエロンβの精製法 |
DE3432083A1 (de) * | 1984-08-31 | 1986-03-06 | Behringwerke Ag, 3550 Marburg | Pasteurisierte, isoagglutininfreie faktor viii-praeparation und verfahren zu ihrer herstellung |
JPS61145200A (ja) * | 1984-12-19 | 1986-07-02 | Snow Brand Milk Prod Co Ltd | ウシラクトフェリンの分離精製法 |
US4613501A (en) * | 1984-12-21 | 1986-09-23 | New York Blood Center, Inc. | Inactivation of viruses in labile blood derivatives |
US4743680A (en) * | 1985-02-01 | 1988-05-10 | New York University | Method for purifying antihemophilic factor |
US4673733A (en) * | 1985-04-11 | 1987-06-16 | Sudhish Chandra | Treatment of biological and pharmaceutical products adsorbed on a solid phase with virus and pyrogen inactivating agents |
JPS61242593A (ja) * | 1985-04-19 | 1986-10-28 | Toray Ind Inc | ヒト・インタ−フエロンβの精製法 |
US4758657A (en) * | 1985-07-11 | 1988-07-19 | Armour Pharmaceutical Company | Method of purifying Factor VIII:C |
US4786726A (en) * | 1986-01-06 | 1988-11-22 | Blood Systems, Inc. | Factor IX therapeutic blood product, means and methods of preparing same |
US4740306A (en) * | 1986-03-17 | 1988-04-26 | Temple University - Of The Commonwealth System Of Higher Education | Chromatographic column |
US4774323A (en) * | 1987-06-29 | 1988-09-27 | Rorer Pharmaceutical Corporation | Purification of von Willebrand Factor solutions using gel permeation chromatography |
US4765903A (en) * | 1987-10-06 | 1988-08-23 | Interferon Sciences, Inc. | Purification of monomeric interferon |
-
1988
- 1988-03-30 CA CA000562932A patent/CA1339946C/en not_active Expired - Lifetime
- 1988-03-31 EP EP88302905A patent/EP0286323B1/en not_active Expired - Lifetime
- 1988-03-31 DE DE3886249T patent/DE3886249T2/de not_active Expired - Lifetime
- 1988-03-31 JP JP63081160A patent/JP2686766B2/ja not_active Expired - Lifetime
- 1988-03-31 ES ES88302905T patent/ES2061642T3/es not_active Expired - Lifetime
- 1988-04-05 DK DK198801840A patent/DK174968B1/da not_active IP Right Cessation
-
1993
- 1993-10-21 US US08140695 patent/US5470954C1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0286323A3 (en) | 1988-11-17 |
JPS6413099A (en) | 1989-01-17 |
DE3886249T2 (de) | 1994-06-30 |
US5470954A (en) | 1995-11-28 |
CA1339946C (en) | 1998-07-07 |
DK184088A (da) | 1988-10-01 |
EP0286323B1 (en) | 1993-12-15 |
DK184088D0 (da) | 1988-04-05 |
ES2061642T3 (es) | 1994-12-16 |
EP0286323A2 (en) | 1988-10-12 |
US5470954C1 (en) | 2001-02-06 |
JP2686766B2 (ja) | 1997-12-08 |
DE3886249D1 (de) | 1994-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK174968B1 (da) | Fremgangsmåde til ultraoprensning af faktor VIII:C | |
Burnouf et al. | A highly purified factor VIII: c concentrate prepared from cryoprecipitate by ion‐exchange chromatography | |
DK175322B1 (da) | Fremgangsmåde til separation af Faktor VIII, fibrinogen, fibronectin og von Willebrands faktor af humane eller animalske plasma og Faktor VIII opnået ved fremgangsmåden | |
US5817528A (en) | Sterile and pyrogen-free columns containing coupled protein for binding and removal of substances from blood | |
US6307028B1 (en) | Chromatographic method for high yield purification and viral inactivation of antibodies | |
US5880265A (en) | Method for isolation of highly pure von willebrand factor | |
RU2337109C2 (ru) | ПРЕПАРАТ ИММУНОГЛОБУЛИНА IgG И СПОСОБ ЕГО ПОЛУЧЕНИЯ | |
US4877866A (en) | Method of producing a virus safe, storage-stable, and intravenously tolerable immunoglobulin-G preparation | |
US4361509A (en) | Ultrapurification of factor VIII using monoclonal antibodies | |
US5679776A (en) | Process for preparing a concentrate of blood coagulation factor VIII-von willebrand factor complex from total plasma | |
US20100305305A1 (en) | Method for purifying factor viii and von willebrand factor | |
CA2009946C (en) | Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof | |
CA2044191A1 (en) | Process for the purification of factor viii and factor viii obtained by said process | |
JPH0580455B2 (es) | ||
EP0600480B1 (en) | Process for the extraction of factor VIII-von willebrand factor (FVIII:C-FVW) complex from total human plasma | |
US7041798B1 (en) | Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use | |
US5006642A (en) | Purification of von Willebrand Factor by affinity chromatography | |
US5688919A (en) | Process for the purification of factor XIII, monoclonal antibodies against factor XIIIA, the preparation and use thereof | |
US20020019036A1 (en) | Von willebrand factor derivatives and methods of isolating proteins that bind to von willebrand factor | |
Ng et al. | Preparation of high purity factor VIII concentrates | |
DK176139B1 (da) | Fremgangsmåde til separation af plasmaproteiner og plasmaproteinkoncentrater opnået ved fremgangsmåden | |
de Lille | Burnouf-Radosevich et a | |
NO870124L (no) | Fremstilling av monomert igg. | |
LV10194B (en) | Blood coagulation factor xi concentrate having high specific activity, suitable for therapeutic use, and process for preparing same | |
CS256705B1 (en) | Method of f(ab)2 fragment separation from f ab, f c,f c fragments obtained by blood gamma-globulin's pepsin-cleavage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |